BDBishnu Das

Bishnu Das

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bishnu Das has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond Light Harvesting: An Excited-State Perspective on Metal–Organic Framework Photocatalysis

    by Bishnu Das

    Photocatalyst design has traditionally relied on light-harvesting descriptors, including absorption strength, band-gap engineering, and charge-separation efficiency, which primarily characterize excited-state generation rather than utilization. Photocatalytic performance is governed by the kinetic fate of the excited state, where productive electron- and energy-transfer pathways compete with radiative and nonradiative decay. Emissive transition-metal complexes in metal–organic frameworks (MOFs) provide tunable platforms for regulating excited-state dynamics. Through confinement, spatial organization, and local environment control, MOFs suppress nonradiative relaxation, promote charge transfer, and stabilize charge-separated states, enabling excited-state pathways often inaccessible in homogeneous systems. Despite progress, quantitative relationships between photophysical properties and catalytic performance remain poorly understood. This Viewpoint proposes an excited-state-centered framework for photocatalysis using emissive MOF systems to establish quantitative structure–photophysics–reactivity relationships.

  • Open Access

    Advances in pH‐Sensitive Luminescent Transition Metal Complexes for Theranostic Applications

    by Bishnu Das, Sakira Tabassum Borah

    PH sensitive luminescent transition metal complexes are emerging as next generation molecular probes for sensing, bioimaging, and cancer theranostics. Small variations in protonation state can markedly influence their photophysical behavior by modulating charge‐transfer processes, excited‐state energetics, and noncovalent interactions, resulting in pronounced and often reversible changes in emission intensity or wavelength. In this review, we examine recent advances in the design of pH‐responsive luminescent transition metal complexes and discuss the mechanistic origins of their pH sensitivity, including protonation‐deprotonation equilibria, hydrogen‐bonding effects, and aggregation‐induced phenomena. Particular emphasis is placed on ruthenium(II) and related complexes, which offer long‐lived excited states, structural robustness, and wide tunability through rational ligand design. We critically analyze representative systems across different metal platforms with respect to their pK a ranges, emission responses, and suitability for biological environments. By highlighting both recent progress and existing limitations, we aim to clarify design strategies that are most likely to translate into reliable tools for real‐time pH sensing, high‐resolution imaging, and multifunctional theranostic applications.


  • Open Access

    Polynuclear transition metal complexes: emerging agents for bacterial imaging and antimicrobial therapy

    by Bishnu Das, Sooraj Sathyanarayan, Parna Gupta

    PTMCs target multidrug-resistant bacteria through ROS production, membrane disruption, and biomolecular interference. Their luminescence properties enable real-time imaging, offering powerful dual-action tools for infection diagnosis and therapy.


  • β-Cyclodextrin Encapsulated Platinum(II)-Based Nanoparticles: Photodynamic Therapy and Inhibition of the NF-κB Signaling Pathway in Glioblastoma

    by Sakira Tabassum Borah, Anushka Mondal, Bishnu Das, Sanchari Saha, Jayasri Das Sarma, Parna Gupta

    This study explores cell death through photodynamic therapy (PDT) with β-cyclodextrin-encapsulated platinum(II)-based nanoparticles (Pt-NPs) and the effect on the NF-κB and stress pathways in glioblastoma. The encapsulation of the cyclometalated Pt(II) complex Pt(LL') within β-cyclodextrin (β-CD) enhances its biocompatibility, improves cellular penetration, and boosts emission, thereby increasing the effectiveness of PDT. Both Pt(LL') and Pt-NPs show minimal toxicity in the dark; however, Pt-NPs significantly increase toxicity toward glioblastoma Kr158 cells upon irradiation at 390 nm. The PDT-induced cell death is further validated through apoptosis assays and the modulation of some key survival pathways like NF-κB/p65, DJ-1, and ERp29. This is the first report of β-cyclodextrin-encapsulated platinum(II)-based nanoparticles designed to target glioblastoma cells through PDT, offering a promising strategy for enhancing therapeutic efficacy.


  • Open Access

    Unveiling mechanistic insights and applications of aggregation-enhanced emission (AEE)-active polynuclear transition metal complexes

    by Bishnu Das

    Aggregation-enhanced emission (AEE) in polynuclear transition metal complexes (PTMCs) represents a major advancement in luminescent materials, overcoming the limitations of aggregation-caused quenching (ACQ) in traditional systems. Unlike conventional materials that suffer from quenching, AEE-active PTMCs exhibit enhanced luminescence in the aggregated state, driven by mechanisms such as restricted molecular motion, π–π stacking, and metal–metal interactions. These properties make PTMCs highly versatile for applications including chemical sensing, bioimaging, photodynamic therapy (PDT), optoelectronics (e.g., OLEDs, WOLEDs, and LEDs), and security technologies (e.g., anti-counterfeiting inks). They enable the sensitive detection of pollutants, facilitate high-performance bioimaging, and enhance the efficiency of energy devices. However, PTMCs face several challenges, including complex synthesis, limited thermal and photostability, solubility issues, and environmental and toxicity concerns. Additionally, high production costs, instability in different media, and the need for optimized energy transfer efficiency must be addressed to enhance their practical performance. This review explores the mechanisms behind AEE in PTMCs and discusses strategies for overcoming these challenges, including ligand engineering, hybrid material development, and sustainable synthesis methods. It also highlights their potential in advancing energy-efficient technologies, precision therapeutics, and secure communication systems, contributing to a more sustainable and innovative future.


  • Total Synthesis of Dixiamycins A and B via a Late-Stage N–N Bond Formation under Visible Light Photoredox Catalysis

    by Rhituparna Nandi, Ranjit Murmu, Sreyashi Sadhukhan, Debopam Pal, Souvik Biswas, Bishnu Das, Alakesh Bisai

    Intermolecular oxidative N-N bond formation reactions are quite challenging and are largely uncharted. N-N linked dimeric indolosesquiterpene alkaloids represent an underexplored class of natural products, and strategies for direct dehydrogenative N-N bond formation are limited. Here, we have reported that a late-stage visible-light photoredox catalysis facilitates N-N bond formation, leading to the total syntheses of atropo-diastereomers dixiamycins A (1a) and B (1b).


  • Transition Metal Complex‐Loaded Nanosystems: Advances in Stimuli‐Responsive Cancer Therapies

    by Bishnu Das

    Transition metal complex‐loaded nanosystems (TMCNs) represent a cutting‐edge platform for stimuli (light, ultrasound)‐responsive cancer therapies. These nanosystems, incorporating metals such as manganese(II), zinc(II), ruthenium(II), rhenium(I), iridium(III), and platinum(IV), significantly enhance the efficacy of light‐activated therapies, including photodynamic therapy (PDT) and photothermal therapy (PTT), as well as ultrasound‐activated treatments like sonodynamic therapy (SDT). TMCNs based on ruthenium(II), rhenium(I), and iridium(III) improve PDT, while manganese(II) and iridium(III) demonstrate exceptional sonosensitizing properties. In PTT, ruthenium(II) and iridium(III)‐based TMCNs efficiently absorb light and generate heat. Emerging synergistic approaches that combine SDT, PTT, PDT, chemotherapy, and immunotherapy are demonstrated to be powerful strategies for precision cancer treatment. Zinc(II), ruthenium(II), iridium(III), and platinum(IV)‐based TMCNs play a critical role in optimizing these therapies, enhancing tumor targeting, and reducing side effects. Furthermore, TMCNs can amplify immunotherapy by inducing immunogenic cell death, thus strengthening the immune response. These advances address key challenges such as tumor hypoxia and therapeutic resistance, opening new possibilities for innovative photosensitizer‐based cancer treatments. This review highlights the latest progress in TMCNs design and applications, demonstrating their potential to revolutionize stimuli‐responsive cancer therapies.


  • Metal complex-based probes for the detection of chloride ions

    by Bishnu Das, Sanwayee Biswas

    Metal complex-based probes enable μM- to nM-level Cl− detection with high selectivity via coordination, H-bonding, electrostatic interactions and more, using techniques such as UV-visible absorption, luminescence, electrochemistry, and 1H NMR.


  • Modulatory Role of Pantropic Cell Signaling Pathways in the Antimigratory and Antiproliferative Action of Triazole Chelated Iridium(III) Complexes in Cervical Cancer Cells

    by Anushka Mondal, Bishnu Das, Souvik Karmakar, Soumili Pani, Shrabani Khan, Parna Gupta, Jayasri Das Sarma

    In the current study, the antimigratory and antiproliferative effect of three substituted triazole-chelated iridium(III) complexes Ir-TRN, Ir-TRH, and Ir-TRF were studied with special emphasis on modulation of P53 activity, a cell cycle regulator. ERK2/MAPK, another crucial cell signaling pathway protein, was also shown to play a crucial role in cell migration and proliferation. The complexes increase the ROS generation within the cell, further supporting apoptotic induction by exerting cellular oxidative stress. These metal complexes also affect ER stress by altering ERp29, an ER-resident chaperone, further inducing the process of apoptosis. The iridium(III) complexes restrict cervical cancer cell migration and proliferation by exerting pronounced effects as P53 activators and downregulation of ERK2/MAPK activity in cervical cancer cells. The underpinning mechanism of P53 and ERK2/MAPK activity in cervical cancer cells in the presence of iridium(III) complexes was studied in detail in this study, which paves the way for developing promising avenues for cancer therapeutics.